About this trial
The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.
Eligibility criteria
Qualifiers
restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)
inpatient treatment indication according to S3 guideline
weight < 3. BMI-percentile or
weight <10. percentile and psychiatric comorbidity/rapid weight loss/lack of weight gain during outpatient treatment over last three month
Disqualifiers
weight <67%mBMI
acute self harm or danger to others
acute psychosis or suicidal tendencies
current substance abuse
Trial design
Treatments tested in this trial
- Family based treatment
- Inpatient multimodal therapy
Treatment groups
Sponsors and collaborators
Charite University, Berlin, Germany
Lead sponsor
Bielefeld University
Collaborator
Techniker Krankenkasse
Collaborator
BARMER
Collaborator
AOK Niedersachsen
Collaborator
Mobil Krankenkasse
Collaborator
Meine Krankenkasse
Collaborator
Medicalnetworks CJ GmbH & Co.KG
Collaborator
AOK Baden-Württemberg
Collaborator
DAK Gesundheit
Collaborator
BIG-direkt
Collaborator
mhplus
Collaborator
Bahn-BKK
Collaborator
OFFIS - Institut für Informatik
Collaborator
Prof. Daniel Le Grange, UCSF
Collaborator